Pavel F. Pavlov
Solna, AB 17164, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Structure-based discovery of small molecule inhibitors of FKBP51-Hsp90 protein-protein interaction.
Journal: European journal of medicinal chemistry
Published: February 06, 2024
FKBP51-Hsp90 Interaction-Deficient Mice Exhibit Altered Endocrine Stress Response and Sex Differences Under High-Fat Diet.
Journal: Molecular neurobiology
Published: April 11, 2023
Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay.
Journal: Journal of visualized experiments : JoVE
Published: August 09, 2021
Small molecule therapeutics for tauopathy in Alzheimer's disease: Walking on the path of most resistance.
Journal: European journal of medicinal chemistry
Published: August 15, 2020
Metal Binding by GMP-1 and Its Pyrimido [1, 2]benzimidazole Analogs Confirms Protection Against Amyloid-β Associated Neurotoxicity.
Journal: Journal of Alzheimer's disease : JAD
Published: December 17, 2019
Development of GMP-1 a molecular chaperone network modulator protecting mitochondrial function and its assessment in fly and mice models of Alzheimer's disease.
Journal: Journal of cellular and molecular medicine
Published: February 06, 2018
Combined x-ray crystallography and computational modeling approach to investigate the Hsp90 C-terminal peptide binding to FKBP51.
Journal: Scientific reports
Published: September 05, 2017
Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.
Journal: Journal of neurochemistry
Published: October 09, 2014
Abnormal platelet amyloid-β protein precursor (AβPP) metabolism in Alzheimer's disease: identification and characterization of a new AβPP isoform as potential biomarker.
Journal: Journal of Alzheimer's disease : JAD
Published: February 08, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026